Original Article
Effects of curcumin on Helicobacter pylori infection
Annals of Translational Medicine
2016;
4
(24)
:479
(December 2016)
Inertia based microfluidic capture and characterisation of circulating tumour cells for the diagnosis of lung cancer
Annals of Translational Medicine
2016;
4
(24)
:480
(December 2016)
Review Article
Gamma-glutamyl transferase and cardiovascular disease
Annals of Translational Medicine
2016;
4
(24)
:481
(December 2016)
Companion diagnostics—a tool to improve pharmacotherapy
Annals of Translational Medicine
2016;
4
(24)
:482
(December 2016)
Case Report
Gastric metastases from gynaecologic tumors: case reports and review of the literature
Annals of Translational Medicine
2016;
4
(24)
:483
(December 2016)
Big-data Clinical Trial Column1
Parametric regression model for survival data: Weibull regression model as an example
Annals of Translational Medicine
2016;
4
(24)
:484
(December 2016)
Editorial
Does relief of outflow tract obstruction in patients with hypertrophic cardiomyopathy improve long-term survival? Implications for lowering the threshold for surgical myectomy and alcohol septal ablation
Annals of Translational Medicine
2016;
4
(24)
:485
(December 2016)
Human behaviour, benign or malevolent: understanding the human psyche, performing therapy, based on affective mentalization and Matte-Blanco’s bi-logic
Annals of Translational Medicine
2016;
4
(24)
:486
(December 2016)
Using epigenomic data to inform genome-wide association studies of bone mineral density
Annals of Translational Medicine
2016;
4
(24)
:487
(December 2016)
Alleviation of gram-negative bacterial lung inflammation by targeting HECTD2
Annals of Translational Medicine
2016;
4
(24)
:488
(December 2016)
Virus vs. virus: adenovirus vectored vaccine to defeat respiratory syncytial virus
Annals of Translational Medicine
2016;
4
(24)
:489
(December 2016)
Circulating microRNA biomarkers for cardiovascular risk prediction: are we approaching clinical application?
Annals of Translational Medicine
2016;
4
(24)
:490
(December 2016)
Clinical utility of novel biomarkers in acute myocardial infarction
Annals of Translational Medicine
2016;
4
(24)
:491
(December 2016)
From static to dynamic: a sepsis-specific dynamic model from clinical criteria in polytrauma patients
Annals of Translational Medicine
2016;
4
(24)
:492
(December 2016)
Genomic predictor of complete response after chemoradiotherapy in rectal cancer
Annals of Translational Medicine
2016;
4
(24)
:493
(December 2016)
The evolving approach to sedation in ventilated patients: a real world perspective
Annals of Translational Medicine
2016;
4
(24)
:494
(December 2016)
Fatty acid-binding proteins as diagnostic and prognostic markers in pneumonia
Annals of Translational Medicine
2016;
4
(24)
:495
(December 2016)
Ventilation in acute respiratory distress syndrome: importance of low-tidal volume
Annals of Translational Medicine
2016;
4
(24)
:496
(December 2016)
Defensin-chemokine heteromeric complexes derived from heterocellular activation—a possible target to inhibit CCL5 in cardiovascular settings
Annals of Translational Medicine
2016;
4
(24)
:497
(December 2016)
Is pulmonary artery pressure a trigger of adverse outcome in mitral regurgitation?
Annals of Translational Medicine
2016;
4
(24)
:498
(December 2016)
An effective DNA vaccine platform for Middle East respiratory syndrome coronavirus
Annals of Translational Medicine
2016;
4
(24)
:499
(December 2016)
Prospects to translate the biology of IL-33 and ST2 during organ transplantation into therapeutics to treat graft-versus-host disease
Annals of Translational Medicine
2016;
4
(24)
:500
(December 2016)
Attempting to define and refine vasopressin use in septic shock: the VANISH trial
Annals of Translational Medicine
2016;
4
(24)
:501
(December 2016)
Early detection of myocardial infarction—microRNAs right at the time?
Annals of Translational Medicine
2016;
4
(24)
:502
(December 2016)
Treatment of non-small cell lung cancer ≤2 cm in size: less may not be more
Annals of Translational Medicine
2016;
4
(24)
:503
(December 2016)
Are we ready to introduce T790M plasma analysis in the follow up of patients with NSCLC under treatment with EGFR-TKI?
Annals of Translational Medicine
2016;
4
(24)
:504
(December 2016)
Do insights from mice imply that combined Th2 and Th17 therapies would benefit select severe asthma patients?
Annals of Translational Medicine
2016;
4
(24)
:505
(December 2016)
Every other day bathing with chlorhexidine gluconate: what is the evidence?
Annals of Translational Medicine
2016;
4
(24)
:506
(December 2016)
Advances in anterior cruciate ligament reconstruction techniques
Annals of Translational Medicine
2016;
4
(24)
:507
(December 2016)
Targeting colorectal cancer (stem-like) cells using LGR5 directed antibody drug conjugates
Annals of Translational Medicine
2016;
4
(24)
:508
(December 2016)
SAMP-ening down sepsis
Annals of Translational Medicine
2016;
4
(24)
:509
(December 2016)
Inhibition of receptor activator of nuclear factor kappa-B ligand pathway for the management of aggressive osteosarcoma
Annals of Translational Medicine
2016;
4
(24)
:510
(December 2016)
Cardiac fibrosis and miR-433
Annals of Translational Medicine
2016;
4
(24)
:511
(December 2016)
The “gut microbiota” hypothesis in primary sclerosing cholangitis
Annals of Translational Medicine
2016;
4
(24)
:512
(December 2016)
Protection against lupus-like inflammatory disease is in the LAP of non-canonical autophagy
Annals of Translational Medicine
2016;
4
(24)
:513
(December 2016)
Volatile anesthetics for lung protection: a bridge between operating rooms and intensive care units?
Annals of Translational Medicine
2016;
4
(24)
:514
(December 2016)
Ultrasound: a novel translational tool to study diaphragmatic dysfunction in critical illness
Annals of Translational Medicine
2016;
4
(24)
:515
(December 2016)
In search for the Holy Grail of cough guidelines
Annals of Translational Medicine
2016;
4
(24)
:516
(December 2016)
Can multispectral optoacoustic tomography replace sentinel lymph biopsy in melanoma?
Annals of Translational Medicine
2016;
4
(24)
:517
(December 2016)
Perspective
Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets
Annals of Translational Medicine
2016;
4
(24)
:518
(December 2016)
Cancer stem cells don’t waste their time cleaning—low proteasome activity, a marker for cancer stem cell function
Annals of Translational Medicine
2016;
4
(24)
:519
(December 2016)
Simian immunodeficiency virus confounds T follicular helper T cells and the germinal centre
Annals of Translational Medicine
2016;
4
(24)
:520
(December 2016)
Focusing the management of rectal cancer
Annals of Translational Medicine
2016;
4
(24)
:521
(December 2016)
P53 mutations and cancer: a tight linkage
Annals of Translational Medicine
2016;
4
(24)
:522
(December 2016)
Targeted nanoparticles for tumour radiotherapy enhancement—the long dawn of a golden era?
Annals of Translational Medicine
2016;
4
(24)
:523
(December 2016)
Potential biomarkers for radiosensitivity in head and neck cancers
Annals of Translational Medicine
2016;
4
(24)
:524
(December 2016)
Anticoagulant independent mechanical heart valves: viable now or still a distant holy grail
Annals of Translational Medicine
2016;
4
(24)
:525
(December 2016)
Improved outcomes with surgery vs. medical therapy in non-thymomatous myesthenia gravis: a perspective on the results of a randomized trial
Annals of Translational Medicine
2016;
4
(24)
:526
(December 2016)
Scoring systems for the characterization of sepsis and associated outcomes
Annals of Translational Medicine
2016;
4
(24)
:527
(December 2016)
Commentary
HECTD2 one step closer to understand susceptibility for acute respiratory disease syndrome?
Annals of Translational Medicine
2016;
4
(24)
:528
(December 2016)
Going into BATTLE: umbrella and basket clinical trials to accelerate the study of biomarker-based therapies
Annals of Translational Medicine
2016;
4
(24)
:529
(December 2016)
Tranexamic acid and total hip arthroplasty: optimizing the administration method
Annals of Translational Medicine
2016;
4
(24)
:530
(December 2016)
Optimum treatment for chronic obstructive pulmonary disease exacerbation prevention
Annals of Translational Medicine
2016;
4
(24)
:531
(December 2016)
Is the revision of a primary TKA really as easy and safe as the revision of a primary UKA?
Annals of Translational Medicine
2016;
4
(24)
:532
(December 2016)
Finding ways to solve or prevent aminoglycoside-induced ototoxicity?
Annals of Translational Medicine
2016;
4
(24)
:533
(December 2016)
RANKL inhibitors for osteosarcoma treatment: hope and caution
Annals of Translational Medicine
2016;
4
(24)
:534
(December 2016)
Is it time for SABR to overtake surgery as the treatment of choice for stage I non-small cell lung cancer?
Annals of Translational Medicine
2016;
4
(24)
:535
(December 2016)
Idolizing the clearance of Amyloid-β by microglia
Annals of Translational Medicine
2016;
4
(24)
:536
(December 2016)
The role of circulating microRNAs in acute coronary syndromes: ready for prime time?
Annals of Translational Medicine
2016;
4
(24)
:537
(December 2016)
Uncovering the influence of the FGFR1 pathway on glioblastoma radiosensitivity
Annals of Translational Medicine
2016;
4
(24)
:538
(December 2016)
MicroRNA-499-5p: a therapeutic target in the context of cardiovascular disease
Annals of Translational Medicine
2016;
4
(24)
:539
(December 2016)
Reconstruction of the medial patellofemoral ligament reconstruction for patients with recurrent patellar dislocation: review of surgical techniques and tips to achieve successful reconstruction
Annals of Translational Medicine
2016;
4
(24)
:540
(December 2016)
Pulmonary hypertension: a long-term risk stratifier in primary mitral regurgitation
Annals of Translational Medicine
2016;
4
(24)
:541
(December 2016)
Should the patella be resurfaced in distal femoral replacement after distal femoral resection?
Annals of Translational Medicine
2016;
4
(24)
:542
(December 2016)
What the blood knows: interrogating circulating tumor DNA to predict progression of minimal residual disease in early breast cancer
Annals of Translational Medicine
2016;
4
(24)
:543
(December 2016)
Polytherapy as first-line in status epilepticus: should we change our practice? “Time is brain”!
Annals of Translational Medicine
2016;
4
(24)
:544
(December 2016)
Targeting NF2-Hippo/Yap signaling pathway for cardioprotection after ischemia/reperfusion injury
Annals of Translational Medicine
2016;
4
(24)
:545
(December 2016)
The downside of human natural killer cell diversity in viral infection revealed by mass cytometry
Annals of Translational Medicine
2016;
4
(24)
:546
(December 2016)
Acquired resistance mechanisms to immunotherapy
Annals of Translational Medicine
2016;
4
(24)
:547
(December 2016)
Therapeutic potential of targeting microRNAs to regulate cardiac fibrosis: miR-433 a new fibrotic player
Annals of Translational Medicine
2016;
4
(24)
:548
(December 2016)
Preclinical randomized controlled multicenter trials (pRCT) in stroke research: a new and valid approach to improve translation?
Annals of Translational Medicine
2016;
4
(24)
:549
(December 2016)
Combining traditional medicine and modern chemistry to fight malaria
Annals of Translational Medicine
2016;
4
(24)
:550
(December 2016)
Micro-RNAs as promising biomarkers in cardiac diseases
Annals of Translational Medicine
2016;
4
(24)
:551
(December 2016)
Anatomic placement of the acetabulum improves the survival rate in patients with Crowe type-II dysplasia undergoing total hip arthroplasty
Annals of Translational Medicine
2016;
4
(24)
:552
(December 2016)
Endothelial progenitor cells and cardiovascular risk: does ageing trump all other factors?
Annals of Translational Medicine
2016;
4
(24)
:553
(December 2016)
Myeloid-derived suppressor cell, arginase-1, IL-17 and cl-CD95L: an explosive cocktail in lupus?
Annals of Translational Medicine
2016;
4
(24)
:554
(December 2016)
Chlorhexidine bathing every other day still does the trick, but it may come at a cost
Annals of Translational Medicine
2016;
4
(24)
:555
(December 2016)
Meet the Professor2
Professor Saumya Das: my experience on cardiology disease and views on it in China
Annals of Translational Medicine
2016;
4
(24)
:556
(December 2016)
Disclosure:
1. The series “Big-data Clinical Trial Column” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.
2. The series “Meet the Professor” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.